Abstract

Group B Streptococcus (GBS) is the leading cause of meningitis in neonates. We have previously shown that plasminogen, once recruited to the GBS cell surface and converted into plasmin by host-derived activators, leads to an enhancement of bacterial virulence. Here, we investigated whether plasmin(ogen) bound at the GBS surface contributes to blood-brain barrier penetration and invasion of the central nervous system. For that purpose, GBS strain NEM316 preincubated with or without plasminogen plus tissue type plasminogen activator was analyzed for the capacity to adhere to, invade and transmigrate the human brain microvascular endothelial cell (hBMEC) monolayer, and to penetrate the central nervous system using a neonatal mouse model. At earlier times of infection, plasmin(ogen)-treated GBS exhibited a significant increase in adherence to and invasion of hBMECs. Later, injury of hBMECs were observed with plasmin(ogen)-treated GBS that displayed a plasmin-like activity. The same results were obtained when hBMECs were incubated with whole human plasma and infected with untreated GBS. To confirm that the observed effects were due to the recruitment and activation of plasminogen on GBS surface, the bacteria were first incubated with epsilon-aminocaproic acid (εACA), an inhibitor of plasminogen binding, and thereafter with plasmin(ogen). A significant decrease in the hBMECs injury that was correlated with a decrease of the GBS surface proteolytic activity was observed. Furthermore, plasmin(ogen)-treated GBS infected more efficiently the brain of neonatal mice than the untreated bacteria, indicating that plasmin(ogen) bound to GBS surface may facilitate the traversal of the blood-brain barrier. A higher survival rate was observed in offspring born from εACA-treated mothers, compared to untreated mice, and no brain infection was detected in these neonates. Our findings suggest that capture of the host plasmin(ogen) by the GBS surface promotes the crossing of the blood-brain barrier and contributes to the establishment of meningitis.

Highlights

  • Group B Streptococcus (GBS), a common designation for Streptococcus agalactiae, is the leading cause of neonatal infectious diseases comprising pneumonia, sepsis, and meningitis [1]

  • GBS adherence to by microvascular endothelial cells (BMECs) constitutes the initial step in the invasion into the central nervous system (CNS) [24] and increased invasiveness is observed when plasmin(ogen) is bound to GBS surface [20]

  • We performed the adhesion and invasion assays in human brain microvascular endothelial cell (hBMEC) by plasmin(ogen)-treated or untreated GBS

Read more

Summary

Introduction

Group B Streptococcus (GBS), a common designation for Streptococcus agalactiae, is the leading cause of neonatal infectious diseases comprising pneumonia, sepsis, and meningitis [1]. Plasmin is a broad-specific protease that can activate other proteolytic enzymes such as the matrix metalloprotease that degrades the tight junction components of microvascular endothelial cells [9]. This destruction may favor the passage of bacteria across the vasculature of the CNS and this scenario was proposed as the mechanism of translocation of B. burgdorferi through the BBB [14]. This study identifies the interaction of GBS with the host plasminogen system as a key mechanism involved in the BBB transmigration and subsequent CNS invasion

Materials and Methods
Results
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.